E. Lerner
16Patents
9h-index
14Co-inventors
69Inventor score
Filing activity: Jan 18, 1996 → Jun 25, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5840332A | Gastrointestinal drug delivery system | Human Necessities | 204 | Expired |
| US7195778B2 | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery | Human Necessities | 146 | Expired |
| US6197331A | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity | Human Necessities | 141 | Expired |
| US6531152B1 | Immediate release gastrointestinal drug delivery system | Human Necessities | 133 | Expired |
| US6632451B2 | Delayed total release two pulse gastrointestinal drug delivery system | Emerging Cross-Sectional Technologies | 79 | Expired |
| US8663703B2 | Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them | Performing Operations; Transporting | 63 | Active |
| US6231888A | Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps | Human Necessities | 60 | Expired |
| US6881420B2 | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation | Human Necessities | 33 | Expired |
| US7611722B2 | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it | Performing Operations; Transporting | 15 | Expired |
| US8188067B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 6 | Active |
| US7674480B2 | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | Human Necessities | 4 | Expired |
| US8653060B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 4 | Active |
| US9375403B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 2 | Active |
| US9180097B2 | Formulations of 6-mercaptopurine | Performing Operations; Transporting | 2 | Active |
| US9107832B2 | Risperidone microparticles formed by sublimation | Performing Operations; Transporting | 0 | Active |
| US7579333B2 | Therapy using a combination of raloxifene and alendronate | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.